Class II recall: Apollo Care, LLC: SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcut
Apollo Care, LLC has issued a Class II recall for SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL sterile multi-dose vials (NDC 71170-495-05), intended for subcutaneous injection. According to the recall notice, the action was prompted by the presence of particulate matter identified as a nylon/polyamide and silk/proteinaceous-type material within the product.
Most relevant for: Patients receiving semaglutide 12.5MG (2.5MG/mL) 5 mL sterile multi-dose vials from Apollo Care, LLC for subcutaneous injection
Read the original at FDA Drug Enforcement ReportsSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More pediatrics updates
- Broad-spectrum antibiotics show no benefit for CAP in complex childrenOct 7, 2026
- AAP Policy Statement Addresses Infection Risks of Raw MilkOct 5, 2026
- Commercial pediatric sepsis alert shows low sensitivity in ED studyOct 5, 2026
- Multi-condition care pathways boost guideline adherence in general hospitalsOct 1, 2026
- AAP revises pediatric UTI diagnostic definition for 2026 guidelineOct 1, 2026